Knowles KN MedTech & Specialty Audio — Adjusted Research and Development Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Knowles in its filing.
Tagged under the XBRL concept kn:AdjustedResearchAndDevelopmentExpenses.
The official record: Knowles’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Knowles's medtech & specialty audio — adjusted research and development expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Knowles's medtech & specialty audio — adjusted research and development expenses?
- Knowles (KN) reported medtech & specialty audio — adjusted research and development expenses of $5M in Q1 2026.
- How has Knowles's medtech & specialty audio — adjusted research and development expenses changed year-over-year?
- Knowles's medtech & specialty audio — adjusted research and development expenses increased by 11.1% year-over-year, from $4.5M to $5M.
- What is the long-term trend for Knowles's medtech & specialty audio — adjusted research and development expenses?
- Over 3 years (2022 to 2025), Knowles's medtech & specialty audio — adjusted research and development expenses has grown at a 5.8% compound annual growth rate (CAGR), from $15.7M to $18.6M.
- What does medtech & specialty audio — adjusted research and development expenses mean?
- The normalized expenditures dedicated to innovation, product design, and technological advancement within the MedTech and Specialty Audio segment. This metric reflects the company's commitment to maintaining a competitive edge and developing future product pipelines.